The role of a key transcription factor PU.1 in autoimmune diseases

被引:12
作者
Fang, Yilong [1 ]
Chen, Weile [1 ]
Li, Zhe [2 ]
Chen, Yu [3 ]
Wu, Xuming [1 ]
Zhu, Xiangling [1 ]
Wang, Huihui [1 ]
Chen, Xiaochun [3 ]
Liang, Qiuni [3 ]
Huang, Jinghua [3 ]
Han, Xintong [3 ]
Hong, Wenming [4 ]
Wang, Xinming [4 ]
Wei, Wei [1 ]
Yu, Zhiying [3 ]
Tu, Jiajie [1 ]
机构
[1] Anhui Med Univ, Inst Clin Pharmacol, Anhui Collaborat Innovat Ctr Antiinflammatory & Im, Key Lab Antiinflammatory & Immune Med,Minist Educ, Hefei, Peoples R China
[2] Southern Med Univ, Clin Med Coll 1, Guangzhou, Peoples R China
[3] Shenzhen Univ, Shenzhen Peoples Hosp 2, Hlth Sci Ctr, Dept Gynecol,Affiliated Hosp 1, Shenzhen, Peoples R China
[4] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China
关键词
PU; 1; autoimmune disease; RA; SLE; EAE; T-CELLS; MACROPHAGES; IL-9; ENCEPHALOMYELITIS; DIFFERENTIATION; EXPRESSION; AXIS;
D O I
10.3389/fimmu.2022.1001201
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
PU.1, a transcription factor member of the E26 transformation-specific family, affects the function of a variety of immune cells in several physiological and pathological conditions. Previous studies studying the role of PU.1 in pathological conditions have mainly focused on immune system-related cancers, and a series of articles have confirmed that PU.1 mutation can induce a variety of immune cell-related malignancies. The underlying mechanism has also been extensively validated. However, the role of PU.1 in other major immune system-related diseases, namely, systemic autoimmune diseases, is still unclear. It was only in recent years that researchers began to gradually realize that PU.1 also played an important role in a variety of autoimmune diseases, such as rheumatoid arthritis (RA), experimental autoimmune encephalomyelitis (EAE) and systemic lupus erythematosus (SLE). This review article summarizes the findings of recent studies that investigated the role of PU.1 in various autoimmune diseases and the related underlying mechanisms. Furthermore, it presents new ideas and provides insight into the role of PU.1 as a potential treatment target for autoimmune diseases and highlights existing research problems and future research directions in related fields.
引用
收藏
页数:9
相关论文
共 43 条
[1]   Reduction of CD19 autoimmunity marker on B cells of paediatric SLE patients through repressing PU.1/TNF-α/BAFF axis pathway by miR-155 [J].
Aboelenein, H. R. ;
Hamza, M. T. ;
Marzouk, H. ;
Youness, R. A. ;
Rahmoon, M. ;
Salah, S. ;
Abdelaziz, A. I. .
GROWTH FACTORS, 2017, 35 (2-3) :49-60
[2]   MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis [J].
Alivernini, Stefano ;
Kurowska-Stolarska, Mariola ;
Tolusso, Barbara ;
Benvenuto, Roberta ;
Elmesmari, Aziza ;
Canestri, Silvia ;
Petricca, Luca ;
Mangoni, Antonella ;
Fedele, Anna Laura ;
Di Mario, Clara ;
Gigante, Maria Rita ;
Gremese, Elisa ;
McInnes, Iain B. ;
Ferraccioli, Gianfranco .
NATURE COMMUNICATIONS, 2016, 7
[3]   Nramp1-mediated innate resistance to intraphagosomal pathogens is regulated by IRF-8, PU.1, and Miz-1 [J].
Alter-Koltunoff, M ;
Ehrlich, S ;
Dror, N ;
Azriel, A ;
Eilers, M ;
Hauser, H ;
Bowen, H ;
Barton, CH ;
Tamura, T ;
Ozato, K ;
Levi, BZ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (45) :44025-44032
[4]   The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis [J].
Burda, P. ;
Laslo, P. ;
Stopka, T. .
LEUKEMIA, 2010, 24 (07) :1249-1257
[5]   Surprising new roles for PU.1 in the adaptive immune response [J].
Carotta, Sebastian ;
Wu, Li ;
Nutt, Stephen L. .
IMMUNOLOGICAL REVIEWS, 2010, 238 :63-75
[6]   The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation [J].
Chang, Hua-Chen ;
Sehra, Sarita ;
Goswami, Ritobrata ;
Yao, Weiguo ;
Yu, Qing ;
Stritesky, Gretta L. ;
Jabeen, Rukhsana ;
McKinley, Carl ;
Ahyi, Ayele-Nati ;
Han, Ling ;
Nguyen, Evelyn T. ;
Robertson, Michael J. ;
Perumal, Narayanan B. ;
Tepper, Robert S. ;
Nutt, Stephen L. ;
Kaplan, Mark H. .
NATURE IMMUNOLOGY, 2010, 11 (06) :527-U98
[7]   Circular RNA circSnx5 Controls Immunogenicity of Dendritic Cells through the miR-544/SOCS1 Axis and PU.1 Activity Regulation [J].
Chen, Qi ;
Mang, Ge ;
Wu, Jian ;
Sun, Ping ;
Li, Tingting ;
Zhang, Hanlu ;
Wang, Naixin ;
Tong, Zhonghua ;
Wang, Weiwei ;
Zheng, Yang ;
Tian, Jinwei ;
Mingyan, E. ;
Zhang, Maomao ;
Yu, Bo .
MOLECULAR THERAPY, 2020, 28 (11) :2503-2518
[8]   NFIL3 deficiency alleviates EAE through regulating different immune cell subsets [J].
Chen, Zhigang ;
Fan, Rong ;
Liang, Jie ;
Xiao, Zexiu ;
Dang, Junlong ;
Zhao, Jun ;
Weng, Ruihui ;
Zhu, Cansheng ;
Zheng, Song Guo ;
Jiang, Ying .
JOURNAL OF ADVANCED RESEARCH, 2022, 39 :225-235
[9]   Synovial IL-9 facilitates neutrophil survival, function and differentiation of Th17 cells in rheumatoid arthritis [J].
Chowdhury, Kaustav ;
Kumar, Uma ;
Das, Soumabha ;
Chaudhuri, Jaydeep ;
Kumar, Prabin ;
Kanjilal, Maumita ;
Ghosh, Parashar ;
Sircar, Geetabali ;
Basyal, Ravi Kiran ;
Kanga, Uma ;
Bandyopadhaya, Santu ;
Mitra, Dipendra Kumar .
ARTHRITIS RESEARCH & THERAPY, 2018, 20
[10]   Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis [J].
Ciccia, Francesco ;
Guggino, Giuliana ;
Rizzo, Aroldo ;
Manzo, Antonio ;
Vitolo, Barbara ;
La Manna, Marco Pio ;
Giardina, Giuseppina ;
Sireci, Guido ;
Dieli, Francesco ;
Montecucco, Carlo Maurizio ;
Alessandro, Riccardo ;
Triolo, Giovanni .
RHEUMATOLOGY, 2015, 54 (12) :2264-2272